Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Applied Therapeutics Inc (DE:2UV)
FRANKFURT:2UV
Holding DE:2UV?
Track your performance easily
Applied Therapeutics (2UV) Ownership Overview
14.39% Insiders
9.99% Mutual Funds
12.22% Other Institutional Investors
17.88% ETFs
45.53% Public Companies and
Individual Investors
The ownership structure of Applied Therapeutics (DE:2UV) stock is a mix of institutional, retail, and individual investors. Approximately 40.08% of the company’s stock is owned by Institutional Investors, 14.39% is owned by Insiders, and 45.53% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
| Aug 23, 2024 | Leslie D. Funtleyder Cfo,director | xxxxxxxxxxxxx | $78880 |
| Aug 23, 2024 | xxxxxxxxxxxxx | $132230 | |
| Aug 14, 2024 | Shoshana Shendelman President & Ceo,director | xxxxxxxxxxxxx | $4712049 |
| Jun 10, 2024 | Leslie D. Funtleyder Cfo,director | xxxxxxxxxxxxx | $73354 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 8,005,000 | Institution | 6.88% | 78,088,775 | |
| 7,309,496 | Insider | 6.28% | 71,304,133 | |
| 6,059,054 | Insider | 5.21% | 59,106,072 | |
| 5,694,671 | Institution | 4.89% | 55,551,516 | |
| 4,982,577 | Institution | 4.28% | 48,605,039 | |
| 4,592,269 | Institution | 3.95% | 44,797,584 | |
| 3,928,416 | Institution | 3.38% | 38,321,698 | |
| 3,450,500 | Institution | 2.97% | 33,659,628 | |
| 2,817,505 | Institution | 2.42% | 27,484,761 | |
| 1,961,072 | Institution | 1.69% | 19,130,257 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 4,592,269 | Institution | 3.95% | 44,797,584 | |
| 3,450,500 | Institution | 2.97% | 33,659,628 | |
| 1,024,356 | Institution | 0.88% | 9,992,593 | |
| 898,813 | Institution | 0.77% | 8,767,921 | |
| 479,719 | Institution | 0.41% | 4,679,659 | |
| 283,370 | Institution | 0.24% | 2,764,274 | |
| 229,153 | Institution | 0.20% | 2,235,388 | |
| 209,348 | Institution | 0.18% | 2,042,190 | |
| 140,000 | Institution | 0.12% | 1,365,700 | |
| 74,673 | Institution | 0.06% | 728,435 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|
FAQ
Who Owns Applied Therapeutics Inc (DE:2UV)?
According to the latest TipRanks data, approximately 12.22% of the company's stock is held by institutional investors, 14.39% is held by insiders, and 45.53% is held by retail investors.
What percentage of Applied Therapeutics Inc (DE:2UV) stock is held by institutional investors?
According to the latest TipRanks data, approximately 12.22% of Applied Therapeutics Inc (DE:2UV) stock is held by institutional investors.
What percentage of Applied Therapeutics Inc (DE:2UV) stock is held by retail investors?
According to the latest TipRanks data, approximately 45.53% of Applied Therapeutics Inc (DE:2UV) stock is held by retail investors.
Who owns the most shares of Applied Therapeutics Inc (DE:2UV)?
Joseph Edelman owns the most shares of Applied Therapeutics Inc (DE:2UV).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.